John P Clancy Selected Research

Amikacin (A.M.K)

1/2015	Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.
5/2014	Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John P Clancy Research Topics

Disease

48	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 11/2003
13	Lung Diseases (Lung Disease) 01/2022 - 10/2013
8	Inflammation (Inflammations) 11/2020 - 02/2006
8	Infections 10/2020 - 04/2014
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 01/2009
2	Pneumonia (Pneumonitis) 11/2018 - 04/2014
2	Fibrosis (Cirrhosis) 01/2018 - 12/2016
2	Acute Kidney Injury (Acute Renal Failure) 10/2015 - 07/2014
2	Pseudomonas Infections 01/2015 - 05/2014
1	High-Frequency Hearing Loss 10/2021
1	Dehydration (Water Stress) 01/2019
1	Joint Diseases (Joint Disease) 01/2019
1	Exocrine Pancreatic Insufficiency 01/2019
1	Asthma (Bronchial Asthma) 12/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2018
1	Lung Neoplasms (Lung Cancer) 12/2018
1	Idiopathic Pulmonary Fibrosis 12/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2018
1	Sepsis (Septicemia) 12/2018
1	Pulmonary Arterial Hypertension 12/2018
1	Airway Remodeling 01/2018
1	Disease Progression 01/2018
1	Bronchopneumonia 01/2017
1	Bronchiolitis Obliterans 12/2016
1	Bronchiectasis 12/2016
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2016
1	Glycogen Storage Disease Type II (Pompe's Disease) 04/2015
1	Respiratory Syncytial Virus Infections 04/2014
1	Osteolysis 08/2011
1	Bone Resorption 08/2011

Drug/Important Bio-Agent (IBA)

13	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2021 - 02/2006
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2007
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2009
5	AminoglycosidesIBA 10/2021 - 07/2007
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2016 - 12/2006
4	ivacaftorIBA 01/2022 - 10/2013
4	ChloridesIBA 01/2022 - 11/2003
2	elexacaftorIBA 01/2022 - 01/2021
2	lumacaftorIBA 01/2022 - 01/2021
2	ivacaftor drug combination tezacaftorIBA 01/2022 - 01/2021
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2021 - 11/2018
2	Protons (Proton)IBA 11/2020 - 01/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 12/2016
2	SodiumIBA 11/2018 - 07/2013
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 01/2014
2	CytokinesIBA 01/2018 - 08/2011
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2016 - 12/2006
2	Amikacin (A.M.K)FDA LinkGeneric 01/2015 - 05/2014
2	Nonsense Codon (Nonsense Mutation)IBA 01/2009 - 07/2007
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	CeramidesIBA 10/2020
1	EnzymesIBA 10/2020
1	SphingolipidsIBA 10/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2020
1	Acid CeramidaseIBA 10/2020
1	Antisense OligonucleotidesIBA 01/2019
1	eluforsenIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Methicillin (Metin)FDA Link 01/2019
1	MucinsIBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2018
1	AntioxidantsIBA 01/2018
1	Ribosomal DNA (rDNA)IBA 11/2017
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2017
1	ElastinIBA 12/2016
1	Expectorants (Mucolytics)IBA 12/2016
1	CollagenIBA 12/2016
1	Contrast MediaIBA 11/2016
1	human GAA protein (Myozyme)FDA Link 04/2015
1	CreatinineIBA 07/2014
1	Leukocyte Elastase (Neutrophil Elastase)IBA 04/2014
1	Tissue Inhibitor of Metalloproteinase-1IBA 04/2014
1	Matrix Metalloproteinases (MMPs)IBA 04/2014
1	Proteins (Proteins, Gene)FDA Link 04/2014
1	Peroxidase (Myeloperoxidase)IBA 04/2014
1	Chloride Channels (Chloride Channel)IBA 01/2014
1	camostatIBA 07/2013
1	prostasinIBA 07/2013
1	Biological ProductsIBA 10/2012
1	ElementsIBA 10/2012
1	LigandsIBA 08/2011
1	NucleosidesIBA 08/2011
1	atalurenIBA 01/2009
1	Terminator Codon (Termination Codon)IBA 01/2009
1	Complementary DNA (cDNA)IBA 08/2007
1	AMP-Activated Protein KinasesIBA 02/2006
1	AerosolsIBA 02/2004
1	NucleotidesIBA 11/2003
1	imidazoleIBA 11/2003
1	SRI 2931IBA 11/2003

Therapy/Procedure

17	Therapeutics 01/2022 - 11/2003
3	Precision Medicine 11/2020 - 10/2012
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2016
1	Enzyme Replacement Therapy 04/2015
1	Intranasal Administration 07/2013
1	Nutritional Support (Artificial Feeding) 12/2006